High materiality7/10
Sabra Health Care price target raised to $21 from $20 at Mizuho
Why it may matterVerify against the original reporting
Upside potential persists.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential persists.
What happened, with direct paths to the underlying reporting
Target raised; current price $20.61.
Target: $21
Posted price: $20.61
Analyst firm: Mizuho Securities
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.